These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

804 related items for PubMed ID: 8164741

  • 1. Mutation in blood coagulation factor V associated with resistance to activated protein C.
    Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH.
    Nature; 1994 May 05; 369(6475):64-7. PubMed ID: 8164741
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Activated protein C resistance--a major risk factor for thrombosis.
    Rosén SB, Sturk A.
    Eur J Clin Chem Clin Biochem; 1997 Jul 05; 35(7):501-16. PubMed ID: 9263726
    [Abstract] [Full Text] [Related]

  • 4. Resistance to activated protein C caused by the R506Q mutation in the gene for factor V is a common risk factor for venous thrombosis.
    Dahlbck B.
    J Intern Med Suppl; 1997 Jul 05; 740():1-8. PubMed ID: 9350175
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Molecular characterization of a type I quantitative factor V deficiency in a thrombosis patient that is "pseudo homozygous" for activated protein C resistance.
    Guasch JF, Lensen RP, Bertina RM.
    Thromb Haemost; 1997 Feb 05; 77(2):252-7. PubMed ID: 9157576
    [Abstract] [Full Text] [Related]

  • 7. Resistance to activated protein C due to mutated factor V as a novel cause of inherited thrombophilia.
    De Stefano V, Leone G.
    Haematologica; 1995 Feb 05; 80(4):344-56. PubMed ID: 7590506
    [Abstract] [Full Text] [Related]

  • 8. Factor V and protein S as cofactors to activated protein C.
    Dahlbäck B.
    Haematologica; 1997 Feb 05; 82(1):91-5. PubMed ID: 9107093
    [Abstract] [Full Text] [Related]

  • 9. Resistance to activated protein C as risk factor for thrombosis: molecular mechanisms, laboratory investigation, and clinical management.
    Dahlbäck B.
    Semin Hematol; 1997 Jul 05; 34(3):217-34. PubMed ID: 9241707
    [Abstract] [Full Text] [Related]

  • 10. "Pseudo homozygous" activated protein C resistance due to double heterozygous factor V defects (factor V Leiden mutation and type I quantitative factor V defect) associated with thrombosis: report of two cases belonging to two unrelated kindreds.
    Simioni P, Scudeller A, Radossi P, Gavasso S, Girolami B, Tormene D, Girolami A.
    Thromb Haemost; 1996 Mar 05; 75(3):422-6. PubMed ID: 8701401
    [Abstract] [Full Text] [Related]

  • 11. Resistance to activated protein C caused by the factor VR506Q mutation is a common risk factor for venous thrombosis.
    Dahlbäck B.
    Thromb Haemost; 1997 Jul 05; 78(1):483-8. PubMed ID: 9198201
    [Abstract] [Full Text] [Related]

  • 12. Activated protein C resistance and thrombosis: molecular mechanisms of hypercoagulable state due to FVR506Q mutation.
    Dahlbäck B.
    Semin Thromb Hemost; 1999 Jul 05; 25(3):273-89. PubMed ID: 10443959
    [Abstract] [Full Text] [Related]

  • 13. Regulation of thrombin formation by activated protein C: effect of the factor V Leiden mutation.
    Tans G, Nicolaes GA, Rosing J.
    Semin Hematol; 1997 Jul 05; 34(3):244-55. PubMed ID: 9241709
    [Abstract] [Full Text] [Related]

  • 14. Homozygous APC-resistance combined with inherited type I protein S deficiency in a young boy with severe thrombotic disease.
    Zöller B, He X, Dahlbäck B.
    Thromb Haemost; 1995 May 05; 73(5):743-5. PubMed ID: 7482396
    [Abstract] [Full Text] [Related]

  • 15. Resistance to activated protein C: a major cause of inherited thrombophilia.
    Jensen R, Ens GE.
    Clin Lab Sci; 1997 May 05; 10(4):219-22. PubMed ID: 10169621
    [Abstract] [Full Text] [Related]

  • 16. Activated protein C resistance: molecular mechanisms.
    Griffin JH, Heeb MJ, Kojima Y, Fernández JA, Kojima K, Hackeng TM, Greengard JS.
    Thromb Haemost; 1995 Jul 05; 74(1):444-8. PubMed ID: 8578503
    [Abstract] [Full Text] [Related]

  • 17. [Activated C protein resistance: laboratory study and prevalence of the defect in the Chilean population].
    Pereira J, Quiroga T, Goycoolea M, Muñoz B, Hidalgo P, Kaltwasser G, Mezzano D.
    Rev Med Chil; 1996 Jun 05; 124(6):663-8. PubMed ID: 9041721
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Congenital and acquired activated protein C resistance.
    Nicolaes GA, Dahlbäck B.
    Semin Vasc Med; 2003 Feb 05; 3(1):33-46. PubMed ID: 15199491
    [Abstract] [Full Text] [Related]

  • 20. Low prevalence of factor V:Q506 in 41 patients with isolated pulmonary embolism.
    Martinelli I, Cattaneo M, Panzeri D, Mannucci PM.
    Thromb Haemost; 1997 Mar 05; 77(3):440-3. PubMed ID: 9065990
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.